4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001593968-23-000168
General Counsel sold 3,000 shares at $7.04 ($21,120)
From the SEC's structured data for this filing
Trades in this filing
Bhavnagri Veer · General Counsel
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-17 | Sale : show line 1 in the form | −3,000 | $7.04 | $21,120 | 580,677 | D |
| Open-market sales · 3,000 sh · avg $7.04 · $21,120 | ||||||
Loading xslF345X03/primary_01.xml…